ATE386743T1 - Pyrimidoverbindungen mit antiproliferativer wirkung - Google Patents
Pyrimidoverbindungen mit antiproliferativer wirkungInfo
- Publication number
- ATE386743T1 ATE386743T1 AT03792269T AT03792269T ATE386743T1 AT E386743 T1 ATE386743 T1 AT E386743T1 AT 03792269 T AT03792269 T AT 03792269T AT 03792269 T AT03792269 T AT 03792269T AT E386743 T1 ATE386743 T1 AT E386743T1
- Authority
- AT
- Austria
- Prior art keywords
- pyrimid
- compounds
- antiproliferative effect
- antiproliferative
- effect
- Prior art date
Links
- 230000001028 anti-proliverative effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40351902P | 2002-08-14 | 2002-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE386743T1 true ATE386743T1 (de) | 2008-03-15 |
Family
ID=31946709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03792269T ATE386743T1 (de) | 2002-08-14 | 2003-08-07 | Pyrimidoverbindungen mit antiproliferativer wirkung |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7084270B2 (de) |
| EP (1) | EP1556384B1 (de) |
| JP (1) | JP2005538141A (de) |
| KR (1) | KR20070087687A (de) |
| CN (1) | CN1323080C (de) |
| AR (1) | AR040971A1 (de) |
| AT (1) | ATE386743T1 (de) |
| AU (1) | AU2003255389A1 (de) |
| BR (1) | BR0313732A (de) |
| CA (1) | CA2494127A1 (de) |
| DE (1) | DE60319255T2 (de) |
| ES (1) | ES2300644T3 (de) |
| MX (1) | MXPA05001629A (de) |
| PA (1) | PA8580001A1 (de) |
| PL (1) | PL375588A1 (de) |
| RU (1) | RU2336275C2 (de) |
| TW (1) | TW200407326A (de) |
| UY (1) | UY27937A1 (de) |
| WO (1) | WO2004018472A2 (de) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008509964A (ja) | 2004-08-31 | 2008-04-03 | エフ．ホフマン−ラ ロシュ アーゲー | ７−アミノ−３−フェニル−ジヒドロピリミド［４，５−ｄ］ピリミジノンのアミド誘導体、これらの製造、及びプロテインキナーゼ阻害剤としての使用 |
| BRPI0514738A (pt) | 2004-08-31 | 2008-06-24 | Hoffmann La Roche | derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos |
| US20120189641A1 (en) | 2009-02-25 | 2012-07-26 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
| JP2012519281A (ja) | 2009-02-27 | 2012-08-23 | オーエスアイ・ファーマシューティカルズ，エルエルシー | 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法 |
| JP2012519282A (ja) | 2009-02-27 | 2012-08-23 | オーエスアイ・ファーマシューティカルズ，エルエルシー | 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法 |
| WO2010099138A2 (en) | 2009-02-27 | 2010-09-02 | Osi Pharmaceuticals, Inc. | Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation |
| WO2012088266A2 (en) | 2010-12-22 | 2012-06-28 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3 |
| US9896730B2 (en) | 2011-04-25 | 2018-02-20 | OSI Pharmaceuticals, LLC | Use of EMT gene signatures in cancer drug discovery, diagnostics, and treatment |
| CN102816162B (zh) * | 2011-06-10 | 2016-04-27 | 中国科学院广州生物医药与健康研究院 | 嘧啶并嘧啶酮类化合物及其药用组合物和应用 |
| WO2013152252A1 (en) | 2012-04-06 | 2013-10-10 | OSI Pharmaceuticals, LLC | Combination anti-cancer therapy |
| CN107383009B (zh) | 2012-06-13 | 2020-06-09 | 因塞特控股公司 | 作为fgfr抑制剂的取代的三环化合物 |
| WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
| WO2014089913A1 (zh) * | 2012-12-12 | 2014-06-19 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的并环化合物 |
| US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
| PE20151776A1 (es) | 2013-03-15 | 2015-12-11 | Celgene Avilomics Res Inc | Compuestos de heteroarilo y sus usos |
| KR102350704B1 (ko) | 2013-03-15 | 2022-01-13 | 셀젠 카르 엘엘씨 | 헤테로아릴 화합물 및 이의 용도 |
| TWI647220B (zh) | 2013-03-15 | 2019-01-11 | 美商西建卡爾有限責任公司 | 雜芳基化合物及其用途 |
| SG11201508328PA (en) | 2013-04-19 | 2015-11-27 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| CN104418860B (zh) * | 2013-08-20 | 2016-09-07 | 中国科学院广州生物医药与健康研究院 | 嘧啶并杂环类化合物及其药用组合物和应用 |
| EP3171874B1 (de) | 2014-07-21 | 2020-11-18 | Dana-Farber Cancer Institute, Inc. | Imidazolylkinasehemmer und verwendungen davon |
| AU2015292827B2 (en) | 2014-07-21 | 2019-11-14 | Dana-Farber Cancer Institute, Inc. | Macrocyclic kinase inhibitors and uses thereof |
| US20170224700A1 (en) | 2014-08-08 | 2017-08-10 | Dana-Farber Cancer Institute, Inc. | Uses of salt-inducible kinase (sik) inhibitors |
| US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
| CN107438607B (zh) | 2015-02-20 | 2021-02-05 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
| CN110225914A (zh) | 2016-07-05 | 2019-09-10 | 布罗德研究所股份有限公司 | 双环脲激酶抑制剂及其用途 |
| US11241435B2 (en) | 2016-09-16 | 2022-02-08 | The General Hospital Corporation | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis |
| KR20190120331A (ko) | 2017-02-28 | 2019-10-23 | 더 제너럴 하스피탈 코포레이션 | Sik 억제제로서의 피리미도피리미디논의 용도 |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| CA3099116A1 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Salts of an fgfr inhibitor |
| AU2019262195B2 (en) | 2018-05-04 | 2024-09-12 | Incyte Corporation | Solid forms of an FGFR inhibitor and processes for preparing the same |
| EP3902804A1 (de) * | 2018-12-27 | 2021-11-03 | Les Laboratoires Servier SAS | Aza-heterobicyclische inhibitoren von mat2a und verfahren zur behandlung von krebs |
| US11628162B2 (en) | 2019-03-08 | 2023-04-18 | Incyte Corporation | Methods of treating cancer with an FGFR inhibitor |
| WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| JP2022552324A (ja) | 2019-10-14 | 2022-12-15 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤としての二環式複素環 |
| US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| CA3163875A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| KR20220131900A (ko) | 2019-12-04 | 2022-09-29 | 인사이트 코포레이션 | Fgfr 억제제의 유도체 |
| WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| US12065494B2 (en) | 2021-04-12 | 2024-08-20 | Incyte Corporation | Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent |
| JP2024522189A (ja) | 2021-06-09 | 2024-06-11 | インサイト・コーポレイション | Ｆｇｆｒ阻害剤としての三環式ヘテロ環 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2949466A (en) | 1958-03-04 | 1960-08-16 | Parke Davis & Co | Pyrimidine compounds and means of producing the same |
| NL6704601A (de) | 1966-04-06 | 1967-10-09 | ||
| US4425346A (en) | 1980-08-01 | 1984-01-10 | Smith And Nephew Associated Companies Limited | Pharmaceutical compositions |
| JPS60226882A (ja) | 1984-04-24 | 1985-11-12 | Nippon Zoki Pharmaceut Co Ltd | 新規ピリミドピリミジン誘導体 |
| WO1998024432A2 (en) | 1996-12-05 | 1998-06-11 | Sugen, Inc. | Use of indolinone compounds as modulators of protein kinases |
| ES2310039T3 (es) | 1998-05-26 | 2008-12-16 | Warner-Lambert Company Llc | Pirimidinas biciclicas y 3,4-dihidropirimidinas biciclicas como inhibidores de la proliferacion celular. |
| ID28276A (id) | 1998-10-23 | 2001-05-10 | Hoffmann La Roche | Heterolingkar nitrogen bisiklik |
| TR200201057T2 (tr) | 1999-10-21 | 2002-09-23 | F.Hoffmann-La Roche Ag | P38 protein kinazı inhibitörleri olarak heteroalkilamino ikameli bisiklik nitrojen heterosaykılları. |
| CZ20021743A3 (cs) | 1999-10-21 | 2002-08-14 | F. Hoffmann-La Roche Ag | Bicyklické dusíkové heterocykly substituované alkylaminoskupinou jako inhibitory P38 proteinkinázy |
| MY141144A (en) | 2000-03-02 | 2010-03-15 | Smithkline Beecham Corp | 1, 5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-dipyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| CN1275964C (zh) | 2000-08-31 | 2006-09-20 | 霍夫曼-拉罗奇有限公司 | 作为细胞增殖抑制剂的7－氧代吡啶并嘧啶 |
| US7196090B2 (en) | 2002-07-25 | 2007-03-27 | Warner-Lambert Company | Kinase inhibitors |
-
2003
- 2003-07-21 US US10/623,972 patent/US7084270B2/en not_active Expired - Fee Related
- 2003-08-07 CN CNB038191601A patent/CN1323080C/zh not_active Expired - Fee Related
- 2003-08-07 JP JP2004530098A patent/JP2005538141A/ja active Pending
- 2003-08-07 AU AU2003255389A patent/AU2003255389A1/en not_active Abandoned
- 2003-08-07 RU RU2005107314/04A patent/RU2336275C2/ru not_active IP Right Cessation
- 2003-08-07 BR BR0313732-5A patent/BR0313732A/pt not_active IP Right Cessation
- 2003-08-07 ES ES03792269T patent/ES2300644T3/es not_active Expired - Lifetime
- 2003-08-07 KR KR1020077017079A patent/KR20070087687A/ko not_active Application Discontinuation
- 2003-08-07 EP EP03792269A patent/EP1556384B1/de not_active Expired - Lifetime
- 2003-08-07 AT AT03792269T patent/ATE386743T1/de not_active IP Right Cessation
- 2003-08-07 PL PL03375588A patent/PL375588A1/xx not_active Application Discontinuation
- 2003-08-07 CA CA002494127A patent/CA2494127A1/en not_active Abandoned
- 2003-08-07 DE DE60319255T patent/DE60319255T2/de not_active Expired - Fee Related
- 2003-08-07 WO PCT/EP2003/008744 patent/WO2004018472A2/en active IP Right Grant
- 2003-08-07 MX MXPA05001629A patent/MXPA05001629A/es active IP Right Grant
- 2003-08-11 PA PA20038580001A patent/PA8580001A1/es unknown
- 2003-08-12 AR ARP030102914A patent/AR040971A1/es not_active Application Discontinuation
- 2003-08-12 UY UY27937A patent/UY27937A1/es not_active Application Discontinuation
- 2003-08-13 TW TW092122274A patent/TW200407326A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2494127A1 (en) | 2004-03-04 |
| US20040038995A1 (en) | 2004-02-26 |
| AR040971A1 (es) | 2005-04-27 |
| CN1323080C (zh) | 2007-06-27 |
| US7084270B2 (en) | 2006-08-01 |
| TW200407326A (en) | 2004-05-16 |
| BR0313732A (pt) | 2005-09-27 |
| DE60319255T2 (de) | 2009-03-05 |
| MXPA05001629A (es) | 2005-04-25 |
| DE60319255D1 (de) | 2008-04-03 |
| UY27937A1 (es) | 2004-02-27 |
| RU2336275C2 (ru) | 2008-10-20 |
| PA8580001A1 (es) | 2004-03-10 |
| KR20070087687A (ko) | 2007-08-28 |
| WO2004018472A3 (en) | 2004-04-29 |
| PL375588A1 (en) | 2005-11-28 |
| RU2005107314A (ru) | 2005-11-20 |
| EP1556384A2 (de) | 2005-07-27 |
| JP2005538141A (ja) | 2005-12-15 |
| ES2300644T3 (es) | 2008-06-16 |
| CN1675214A (zh) | 2005-09-28 |
| WO2004018472A2 (en) | 2004-03-04 |
| EP1556384B1 (de) | 2008-02-20 |
| AU2003255389A1 (en) | 2004-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE386743T1 (de) | Pyrimidoverbindungen mit antiproliferativer wirkung | |
| DE60332125D1 (de) | Indole mit antidiabetischer wirkung | |
| DE60318287D1 (de) | Zerstäuber mit diskreten Strahlen | |
| DE602004029705D1 (de) | 5,7-diaminopyrazoloä4,3-düpyrimidine mit pde-5-hemmender wirkung | |
| DK1487805T3 (da) | Pyrimidinderivater | |
| DE60319260D1 (de) | Pyrimidoderivate mit antiproliferativer aktivität (ii) | |
| FI20020394A (fi) | Valotutka | |
| ATE473985T1 (de) | Tricyclische tetrahydrochinoline mit antibakterieller wirkung | |
| ATE446750T1 (de) | 3-cyano-chinolin-derivate mit antiproliferativer wirkung | |
| ATE361282T1 (de) | Indazol-aminoacetonitrilderivate mit pestizider wirkung | |
| DE60328272D1 (de) | Diazabicycloalkan-derivate mit nk1-antagonistischer wirkung | |
| DE60315984D1 (de) | Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung | |
| IS7421A (is) | Frásogshvati | |
| DE602004017199D1 (de) | Silikonverbindungen mit mikrobizider wirkung | |
| FR2844817B1 (fr) | Element de coffrage | |
| FI5659U1 (fi) | Lana | |
| ITUD20020081A1 (it) | Profilo luminoso polifunzionale | |
| ITUD20020026U1 (it) | Profilo luminoso polifunzionale | |
| FI5717U1 (fi) | Kynttiläteline | |
| ITRE20020018A1 (it) | Denocciolatrice | |
| DK1539233T3 (da) | Humaniserede super-antistoffer | |
| UA7380S (uk) | Профіль | |
| UA7727S (uk) | Профіль | |
| UA6170S (uk) | Профіль | |
| UA6172S (uk) | Профіль |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1556384 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |